Is fluorometric sentinel lymph node biopsy in endometrial cancer necessary?

被引:0
|
作者
Huang, Liqiong [1 ]
Cheng, Wei [2 ]
He, Chenghui [1 ]
Li, Xin [2 ]
Huang, Lu [2 ]
Zhang, Jiajia [2 ]
Song, Liwen [1 ]
Zhou, Yifan [1 ]
Wang, Chenchen [3 ]
Gan, Xiaoqin [2 ]
Qiu, Jin [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Tongren Hosp, Dept Obstet & Gynecol, Sch Med, Shanghai, Peoples R China
[2] Univ Elect Sci & Technol China, Chengdu Womens & Childrens Cent Hosp, Dept Obstet & Gynecol, Chengdu, Sichuan, Peoples R China
[3] Shanghai United Family Pudong Hosp, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
endometrial cancer; SLNB; case-control study; prognosis; surgery; LYMPHADENECTOMY; METASTASIS;
D O I
10.3389/fmed.2024.1434311
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective In this study, we collected perioperative and postoperative follow-up data from patients with endometrial cancer (EC) at different stages to evaluate the role of sentinel lymph node biopsy (SLNB) in endometrial cancer surgery.Methods A total of 186 endometrial cancer patients undergoing radical hysterectomy from January 2018 to April 2022 were retrospectively analyzed. Patients were classified into four groups. Group A comprised patients diagnosed with stage IA grade 1 and 2 endometrioid EC who underwent SLNB. Group B comprised patients with stage IA grade 1 and 2 endometrioid EC who did not undergo SLNB. Group C comprised patients with higher-grade endometrioid EC, wherein systematic lymph node dissection was performed based on SLNB results. Group D comprised patients with higher-grade endometrioid EC who did not undergo SLNB and instead underwent direct systematic lymph node dissection. Clinical, pathological data, and follow-up information for all patients were collected.Results In Group A and B, SLNB was performed on 36 out of 67 patients with IA stage 1 and 2 endometrial cancer, yielding a SLN positivity rate of 5.6%. There were no significant differences observed between the two groups regarding perioperative outcomes and postoperative follow-up. Conversely, among 119 patients with higher-grade endometrial cancer, 52 underwent SLNB, with 20 patients exhibiting SLN positivity, resulting in a SLN positivity rate of 38.4%. However, the decision to undergo SLNB did not yield significant differences in perioperative outcomes and postoperative follow-up among these patients.Conclusion For stage IA grade 1 and 2 endometrioid EC, the incidence of lymph node positivity is low, omitting SLNB in this subpopulation is a feasible option. In other stages of endometrioid EC, there is no significant difference in perioperative and postoperative follow-up data between patients undergoing routine systematic lymphadenectomy and those undergoing systematic lymphadenectomy based on SLNB results. Therefore, if SLNB is not available, the standard procedure of PLND remains an option to obtain information about lymph node status, despite the surgical complications associated with this procedure.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] SENTINEL LYMPH NODE BIOPSY IN ENDOMETRIAL AND CERVICAL CANCER
    Dogan, S.
    Aydin, H. Ayik
    Simsek, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 332 - 332
  • [2] Sentinel Lymph Node Biopsy in Endometrial and Cervical Cancer
    Papathomas, Daphne
    Andrade, Fausto Francisco
    Estape, Ricardo E.
    Nasseri-Nik, Niloofar
    Schroeder, Eric
    Diaz, John Paul
    OBSTETRICS AND GYNECOLOGY, 2015, 125 : 106S - 106S
  • [3] Status of Sentinel Lymph Node Biopsy in Endometrial Cancer
    Taran, Florin Andrei
    Jung, Lisa
    Waldschmidt, Julia
    Huwer, Sarah Isabelle
    Juhasz-Boess, Ingolf
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2021, 81 (05) : 562 - 573
  • [4] Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer
    Nagar, Hans
    Wietek, Nina
    Goodall, Richard J.
    Hughes, Will
    Schmidt-Hansen, Mia
    Morrison, Jo
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (06):
  • [5] USEFULNESS OF THE SENTINEL LYMPH NODE BIOPSY IN PATIENTS WITH ENDOMETRIAL CANCER
    Gomez Rodriguez, T.
    Sanz Viedma, S.
    Gonzalez Garcia, L. F.
    Ana Maria, F. M.
    Luis Miguel, C. M.
    Jose Luis, O. P.
    Irene, E. L.
    Agustin Jose, E. M.
    Omar, R.
    Gonzalo, S. D. C.
    Maria Victoria, O. J.
    Maria Pilar, E. R.
    Marina, D. L. T. B.
    Irene, S. U.
    Raquel, R. P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1946 - 1946
  • [6] Sentinel lymph node biopsy in endometrial cancer: state of the art
    Della Corte, Luigi
    Giampaolino, Pierluigi
    Mercorio, Antonio
    Riemma, Gaetano
    Schiattarella, Antonio
    De Franciscis, Pasquale
    Bifulco, Giuseppe
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (12) : 7725 - 7733
  • [7] Applications and Safety of Sentinel Lymph Node Biopsy in Endometrial Cancer
    Chiu, Wan Kam
    Kwok, Shuk Tak
    Wang, Yaokai
    Luk, Hiu Mei
    Chan, Aaron Hei Yin
    Tse, Ka Yu
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (21)
  • [8] Sentinel lymph node biopsy in breast cancer - is lymphoscintigraphy really necessary?
    Upponi, SS
    McIntosh, SA
    Wishart, GC
    Balan, KK
    Purushotham, AD
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2002, 28 (05): : 479 - 480
  • [9] Sentinel lymph node biopsy in breast cancer - is lymphoscintigraphy really necessary?
    Upponi, SS
    McIntosh, SA
    Wishart, GC
    Balan, KK
    Purushotham, AD
    BRITISH JOURNAL OF SURGERY, 2001, 88 : 33 - 33
  • [10] Sentinel Lymph Node Biopsy in Endometrial Cancer: a New Standard of Care?
    Stephanie A. Sullivan
    Emma C. Rossi
    Current Treatment Options in Oncology, 2017, 18